Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With 2022 in the rearview mirror, it’s time to hunt for solid, undervalued long-term stocks to buy. First, it’s essential to define what is meant by long-term. Secondly, we need to classify what makes a stoc...
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results PR Newswire Preliminary full year 2022 HEPLISAV-B ® vaccine Net Product Revenue of approximately $126 million , representing 104% ...
Summary Shares of biopharmaceutical concern Ardelyx, Inc. have fallen over 60% since the FDA initially rejected its hyperphosphatemia therapy XPHOZOA (tenapanor) in mid-2021. The rejection, which was very surprising given its three Phase 3 trial successes, compelled Ardelyx to lay off ~...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the more fun assignments at InvestorPlace is selecting the top small-cap stock picks for 2023. In this case, I’ve been chosen to provide readers with seven options for next year. While I’ve alrea...
-- The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo -- -- Results indicate that ...
Dynavax to Present at Two Upcoming Investor Conferences PR Newswire EMERYVILLE, Calif. , Nov. 9, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovati...
Summary Vaccine play Dynavax Technologies once again delivered stellar quarterly results after the bell on Thursday. Despite this, the stock continues to get a muted reaction from the investment community. Investors seem to be overlooking some significant value in this name....
Image source: The Motley Fool. Dynavax Technologies (NASDAQ: DVAX) Q3 2022 Earnings Call Nov 03, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript
Dynavax Technologies Corporation (DVAX) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Nicole Arndt - Senior Manager, IR Ryan Spencer - CEO Donn Casale - SVP, Commercial Rob Janssen - CMO Kelly MacDonald - CFO Co...
The following slide deck was published by Dynavax Technologies Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Dynavax Technologies Corporation 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 PR Newswire EMERYVILLE, Calif. , July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company dev...
Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program PR Newswire EMERYVILLE, Calif. , June 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing inn...
2024-06-21 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...